FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jan Albert

Research Profile

Living Beings

HIV-1
HIV-2

Disorders

Concepts & Ideas

Chemicals & Drugs

Physiology

Procedures

Genes & Molecular Sequences

Amino Acid Sequences

Anatomy

Leukocytes, Mononuclear

Co-author Network

Publications

TOP 3
Helena Skar; Jan Albert; Thomas Leitner
Towards Estimation of HIV-1 Date of Infection: A Time-Continuous IgG-Model Shows That Seroconversion Does Not Occur at the Midpoint between Negative and Positive Tests.
Irene Bontell; Göran Bratt; Amanda Häggblom; Jan Albert; Anders Sönnerborg
Trends in antiretroviral therapy and prevalence of HIV drug resistance mutations in Sweden 1997-2011.
Wendy Murillo; Ana Isabel Nieto; Jan Albert; María Elena Guardado; Ivette Lorenzana de Rivera; Gabriela Paz-Bailey
Prevalence of transmitted HIV-1 drug resistance among female sex workers and men who have sex with men in El Salvador, Central America.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jan Albert (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Helena Skar; Jan Albert; Thomas Leitner
Towards Estimation of HIV-1 Date of Infection: A Time-Continuous IgG-Model Shows That Seroconversion Does Not Occur at the Midpoint between Negative and Positive Tests.
PloS one 2013;8(4):e60906.
2013: Irene Bontell; Göran Bratt; Amanda Häggblom; Jan Albert; Anders Sönnerborg
Trends in antiretroviral therapy and prevalence of HIV drug resistance mutations in Sweden 1997-2011.
PloS one 2013;8(3):e59337.
2012: Wendy Murillo; Ana Isabel Nieto; Jan Albert; María Elena Guardado; Ivette Lorenzana de Rivera; Gabriela Paz-Bailey
Prevalence of transmitted HIV-1 drug resistance among female sex workers and men who have sex with men in El Salvador, Central America.
Journal of medical virology 2012;84(10):1514-21.
2012: Dace Balode; Andris Ferdats; Tatjana Kolupajeva; Thomas Leitner; Mattias Mild; Baiba Rozentale; Helena Skar; Jan Albert
Phylogenetic analysis of the Latvian HIV-1 epidemic.
AIDS research and human retroviruses 2012;28(8):928-32.
2012: Annika Karlsson; Mattias Mild; Anders Sönnerborg; Per Björkman; Göran Bratt; Håkan Ekvall; Magnus Gisslen; Jan Albert
Low prevalence of transmitted drug resistance in patients newly diagnosed with HIV-1 infection in Sweden 2003-2010.
PloS one 2012;7(3):e33484.
2011: Helena Skar; Charlotte Hedskog; Jan Albert
HIV-1 evolution in relation to molecular epidemiology and antiretroviral resistance.
Annals of the New York Academy of Sciences 2011;1230():108-18.
2011: Lina Josefsson; Mary F Kearney; Martin S King; Barbro Makitalo; Frank Maldarelli; John W Mellors; Jan Albert; Johan Brännström; Jianbo Chen; John M Coffin; Hans Gaines; Wei-Shau Hu; Wei Shao; Sarah E Palmer
Majority of CD4+ T cells from peripheral blood of HIV-1-infected individuals contain only one HIV DNA molecule.
Proceedings of the National Academy of Sciences of the United States of America 2011;108(27):11199-204.
2011: Lars Navér; Karin Pettersson; Anders Sönnerborg; Veronica Svedhem; Katarina Westling; Aylin Yilmaz; Jan Albert; Erik Belfrage; Leo Flamholc; Magnus Gisslen; Katarina Gyllensten; Filip Josephson; Olle Karlström; Susanne Lindgren
Prophylaxis and treatment of HIV-1 infection in pregnancy: Swedish recommendations 2010.
Scandinavian journal of infectious diseases 2011;43(6-7):411-23.
2011: Helena Skar; Karin Wilbe Ramsay; Annette Alaeus; Jan Albert; Ryan N Gutenkunst; Thomas Leitner
Daily sampling of an HIV-1 patient with slowly progressing disease displays persistence of multiple env subpopulations consistent with neutrality.
PloS one 2011;6(8):e21747.
2011: Mattias Mild; Charlotte Hedskog; Johanna Jernberg; Jan Albert
Performance of ultra-deep pyrosequencing in analysis of HIV-1 pol gene variation.
PloS one 2011;6(7):e22741.
2011: Marie Borggren; Melissa J Churchill; Eva Maria Fenyö; Paul R Gorry; Anders Karlsson; Johanna Repits; Jasminka Sterjovski; Hannes Uchtenhagen; Adnane Achour; Jan Albert; Marianne Jansson
Increased sensitivity to broadly neutralizing antibodies of end-stage disease R5 HIV-1 correlates with evolution in Env glycosylation and charge.
PloS one 2011;6(6):e20135.
2011: Helena Skar; Maria Axelsson; Ingela Berggren; Anders Thalme; Katarina Gyllensten; Kirsi Liitsola; Henrikki Brummer-Korvenkontio; Pia Kivelä; Erika Spångberg; Thomas Leitner; Jan Albert
Dynamics of two separate but linked HIV-1 CRF01_AE outbreaks among injection drug users in Stockholm, Sweden, and Helsinki, Finland.
Journal of virology 2011;85(1):510-8.
2010: Dace Balode; Maj Westman; Tatjana Kolupajeva; Baiba Rozentale; Jan Albert
Low prevalence of transmitted drug resistance among newly diagnosed HIV-1 patients in Latvia.
Journal of medical virology 2010;82(12):2013-8.
2010: Helena Skar; Pedro Borrego; Timothy C Wallstrom; Mattias Mild; Jose Maria Marcelino; Helena Barroso; Nuno Taveira; Thomas Leitner; Jan Albert
HIV-2 genetic evolution in patients with advanced disease is faster than that in matched HIV-1 patients.
Journal of virology 2010;84(14):7412-5.
2010: Salma Nowroozalizadeh; Fredrik Månsson; Zacarias da Silva; Johanna Repits; Braima Dabo; Carla Pereira; Antonio Biague; Jan Albert; Jens Nielsen; Peter Aaby; Eva Maria Fenyö; Hans Norrgren; Birgitta Holmgren; Marianne Jansson
Microbial translocation correlates with the severity of both HIV-1 and HIV-2 infections.
The Journal of infectious diseases 2010;201(8):1150-4.
2010: Mark A Wainberg; Jan Albert
Can the further clinical development of bevirimat be justified?
AIDS (London, England) 2010;24(5):773-4.
2010: Charlotte Hedskog; Mattias Mild; Johanna Jernberg; Ellen Sherwood; Göran Bratt; Thomas Leitner; Joakim Lundeberg; Björn Andersson; Jan Albert
Dynamics of HIV-1 quasispecies during antiviral treatment dissected using ultra-deep pyrosequencing.
PloS one 2010;5(7):e11345.
2010: Mattias Mild; Melinda Simon; Jan Albert; Ali Mirazimi
Towards an understanding of the migration of Crimean-Congo hemorrhagic fever virus.
The Journal of general virology 2010;91(Pt 1):199-207.
2009: Salma Nowroozalizadeh; Fredrik Månsson; Zacarias da Silva; Johanna Repits; Braima Dabo; Carla Pereira; Antonio Biague; Jan Albert; Jens Nielsen; Peter Aaby; Eva Maria Fenyö; Hans Norrgren; Birgitta Holmgren; Marianne Jansson
Studies on toll-like receptor stimuli responsiveness in HIV-1 and HIV-2 infections.
Cytokine 2009;46(3):325-31.
2009: Filip Josephson; Jan Albert; Leo Flamholc; Magnus Gisslen; Olle Karlström; Lars Moberg; Lars Navér; Veronica Svedhem; Bo Svennerholm; Anders Sönnerborg
Treatment of HIV infection: Swedish recommendations 2009.
Scandinavian journal of infectious diseases 2009;41(11-12):788-807.
2008: Johanna Repits; Jasminka Sterjovski; Daniel Badia-Martinez; Mattias Mild; Lachlan Gray; Melissa J Churchill; Damian F J Purcell; Anders Karlsson; Jan Albert; Eva Maria Fenyö; Adnane Achour; Paul R Gorry; Marianne Jansson
Primary HIV-1 R5 isolates from end-stage disease display enhanced viral fitness in parallel with increased gp120 net charge.
Virology 2008;379(1):125-34.
2008: Helena Skar; Staffan Sylvan; Hans Bertil Hansson; Olle Gustavsson; Hans Boman; Jan Albert; Thomas Leitner
Multiple HIV-1 introductions into the Swedish intravenous drug user population.
Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases 2008;8(5):545-52.
2008: Lars Navér; Ann-Britt Bohlin; Jan Albert; Leo Flamholc; Magnus Gisslén; Katarina Gyllensten; Filip Josephson; PehrOlov Pehrson; Anders Sönnerborg; Katarina Westling; Susanne Lindgren
Prophylaxis and treatment of HIV-1 infection in pregnancy: Swedish Recommendations 2007.
Scandinavian journal of infectious diseases 2008;40(6-7):451-61.
2007: Sabelle Jallow; Steve Kaye; Martin Schutten; Eleonor Brandin; Jan Albert; Samuel J McConkey; Tumani Corrah; Hilton Whittle; Guido Vanham; Sarah Rowland-Jones; Wouter Janssens
Development and evaluation of an oligonucleotide ligation assay for detection of drug resistance-associated mutations in the human immunodeficiency virus type 2 pol gene.
Journal of clinical microbiology 2007;45(5):1565-71.
2007: Filip Josephson; Jan Albert; Leo Flamholc; Magnus Gisslen; Olle Karlström; Susanne-Rosa Lindgren; Lars Navér; Eric Sandström; Veronica Svedhem-Johansson; Bo Svennerholm; Anders Sönnerborg
Antiretroviral treatment of HIV infection: Swedish recommendations 2007.
Scandinavian journal of infectious diseases 2007;39(6-7):486-507.
2006: Eleonor Brandin; Rigmor Thorstensson; Sebastian Bonhoeffer; Jan Albert
Rapid viral decay in simian immunodeficiency virus-infected macaques receiving quadruple antiretroviral therapy.
Journal of virology 2006;80(19):9861-4.
2006: Claudia Devito; Bo Hejdeman; Jan Albert; Kristina Broliden; Jorma Hinkula
Antiretroviral therapy does not induce HIV type 1-specific neutralizing activity against autologous HIV type 1 isolates.
AIDS research and human retroviruses 2006;22(9):908-11.
2006: Anna Lindström; Anna Ohlis; Marleen C D G Huigen; Monique Nijhuis; Torsten Berglund; Göran Bratt; Eric Sandström; Jan Albert
HIV-1 transmission cluster with M41L 'singleton' mutation and decreased transmission of resistance in newly diagnosed Swedish homosexual men.
Antiviral therapy 2006;11(8):1031-9.
2006: Magnus Gisslen; Jane Ahlqvist Rastad; Jan Albert; Anders Blaxhult; Anna-Karin Hamberg; Stefan Lindbäck; Eric Sandström; Ingrid Uhnoo
Antiretroviral treatment of HIV infection: Swedish recommendations 2005.
Scandinavian journal of infectious diseases 2006;38(2):86-103.
2005: Charlotte Casper; Mattias Mild; Marianne Jansson; Anders Karlsson; Viveca Holmberg; Göran Bratt; Hubertus Van Paaschen; Peter Biberfeld; Asa Björndal; Jan Albert; Mikulas Popovic; Eva Maria Fenyö
Coreceptor usage of primary HIV type 1 isolates obtained from different lymph node subsets.
AIDS research and human retroviruses 2005;21(12):1003-10.
2005: Yu Shi; Eleonor Brandin; Elzbieta Vincic; Marianne Jansson; Anders Blaxhult; Katarina Gyllensten; Lars Moberg; Christina Broström; Eva Maria Fenyö; Jan Albert
Evolution of human immunodeficiency virus type 2 coreceptor usage, autologous neutralization, envelope sequence and glycosylation.
The Journal of general virology 2005;86(Pt 12):3385-96.
2005: Eleonor Brandin; Christina Broström; Elena Gille; Sebastian Bonhoeffer; Jan Albert
Short communication: HIV type 2 dynamics.
AIDS research and human retroviruses 2005;21(7):608-10.
2004: Nicklas Arvidson; Magnus Gisslen; Jan Albert; Eleonor Brandin; Bo Svennerholm; Dietmar Fuchs; Lars Hagberg
Cerebrospinal fluid viral load, virus isolation, and intrathecal immunoactivation in HIV type 2 infection.
AIDS research and human retroviruses 2004;20(7):711-5.
2003: Karin Wilbe; Mika Salminen; Tiina Laukkanen; Francine E McCutchan; Stuart C Ray; Jan Albert; Thomas Leitner
Characterization of novel recombinant HIV-1 genomes using the branching index.
Virology 2003;316(1):116-25.
2003: Magnus Unemo; Per Olcén; Jan Albert; Hans Fredlund
Comparison of serologic and genetic porB-based typing of Neisseria gonorrhoeae: consequences for future characterization.
Journal of clinical microbiology 2003;41(9):4141-7.
2003: Eleonor Brandin; Lena Lindborg; Katarina Gyllensten; Christina Broström; Lars Hagberg; Magnus Gisslen; Björn Tuvesson; Anders Blaxhult; Jan Albert
pol gene sequence variation in Swedish HIV-2 patients failing antiretroviral therapy.
AIDS research and human retroviruses 2003;19(7):543-50.
2003: Anna Lindström; Jan Albert
A simple and sensitive 'in-house' method for determining genotypic drug resistance in HIV-1.
Journal of virological methods 2003;107(1):45-51.
2002: Magnus Unemo; Per Olcén; Torsten Berglund; Jan Albert; Hans Fredlund
Molecular epidemiology of Neisseria gonorrhoeae: sequence analysis of the porB gene confirms presence of two circulating strains.
Journal of clinical microbiology 2002;40(10):3741-9.
2002: Charlotte Casper; Peter Clevestig; Elisabeth Carlenor; Thomas Leitner; Bo Anzén; Knut Lidman; Erik Belfrage; Jan Albert; Ann-Britt Bohlin; Lars Navér; Susanne Lindgren; Eva Maria Fenyö; Anneka Ehrnst
Link between the X4 phenotype in human immunodeficiency virus type 1-infected mothers and their children, despite the early presence of R5 in the child.
The Journal of infectious diseases 2002;186(7):914-21.
2002: Y Shi; Jan Albert; G Francis; H Holmes; Eva Maria Fenyö
A new cell line-based neutralization assay for primary HIV type 1 isolates.
AIDS research and human retroviruses 2002;18(13):957-67.
2002: Karin Wilbe; Charlotte Casper; Jan Albert; Thomas Leitner
Identification of two CRF11-cpx genomes and two preliminary representatives of a new circulating recombinant form (CRF13-cpx) of HIV type 1 in Cameroon.
AIDS research and human retroviruses 2002;18(12):849-56.
2002: Charlotte Casper; Lars Navér; Peter Clevestig; Erik Belfrage; Thomas Leitner; Jan Albert; Susanne Lindgren; C Ottenblad; Ann-Britt Bohlin; Eva Maria Fenyö; Anneka Ehrnst
Coreceptor change appears after immune deficiency is established in children infected with different HIV-1 subtypes.
AIDS research and human retroviruses 2002;18(5):343-52.
2002: Andreas Mörner; Asa Björndal; Ann-Charlotte Boström; Jan Albert; Ewa Björling; Marianne Jansson
CCR5 or CXCR4 is required for efficient infection of peripheral blood mononuclear cells by promiscuous human immunodeficiency virus type 2 primary isolates.
AIDS research and human retroviruses 2002;18(3):193-200.
2001: Marianne Jansson; E Backström; Gabriella Scarlatti; Asa Björndal; S Matsuda; Paolo Rossi; Jan Albert; Hans Wigzell
Length variation of glycoprotein 120 V2 region in relation to biological phenotypes and coreceptor usage of primary HIV type 1 isolates.
AIDS research and human retroviruses 2001;17(15):1405-14.
2001: Deirdre O'Meara; Karin Wilbe; Thomas Leitner; B Hejdeman; Jan Albert; Joakim Lundeberg
Monitoring resistance to human immunodeficiency virus type 1 protease inhibitors by pyrosequencing.
Journal of clinical microbiology 2001;39(2):464-73.
2001: M Nygren; Mostafa Ronaghi; Pål Nyrén; Jan Albert; Joakim Lundeberg
Quantification of HIV-1 using multiple quantitative polymerase chain reaction standards and bioluminometric detection.
Analytical biochemistry 2001;288(1):28-38.
2000: Sören Andersson; Hans Norrgren; Zacarias da Silva; Antonio Biague; S Bamba; S Kwok; C Christopherson; Gunnel Biberfeld; Jan Albert
Plasma viral load in HIV-1 and HIV-2 singly and dually infected individuals in Guinea-Bissau, West Africa: significantly lower plasma virus set point in HIV-2 infection than in HIV-1 infection.
Archives of internal medicine 2000;160(21):3286-93.
2000: Angelo De Milito; Bo Hejdeman; Jan Albert; S Aleman; Anders Sönnerborg; Maurizio Zazzi; Francesca Chiodi
High plasma levels of soluble fas in HIV type 1-infected subjects are not normalized during highly active antiretroviral therapy.
AIDS research and human retroviruses 2000;16(14):1379-84.
2000: C Tscherning-Casper; Guillermina Dolcini; Philippe Mauclère; Eva Maria Fenyö; Françoise Barré-Sinoussi; Jan Albert; Elisabeth Menu
Evidence of the existence of a new circulating recombinant form of HIV type 1 subtype A/J in Cameroon. The European Network on the Study of In Utero Transmission of HIV-1.
AIDS research and human retroviruses 2000;16(13):1313-8.
2000: C Tscherning-Casper; Dalma Vödrös; Elisabeth Menu; K Aperia; R Fredriksson; Guillermina Dolcini; Gérard Chaouat; Françoise Barré-Sinoussi; Jan Albert; Eva Maria Fenyö
Coreceptor usage of HIV-1 isolates representing different genetic subtypes obtained from pregnant Cameroonian women. European Network for In Utero Transmission of HIV-1.
Journal of acquired immune deficiency syndromes (1999) 2000;24(1):1-9.
2000: Ann-Charlotte Boström; G Gilljam; Malin Fredriksson; Jorma Hinkula; Annette Alaeus; Knut Lidman; Jan Albert; Göran Bratt; Eric Sandström; Britta Wahren
Cross-reactive T-helper responses in patients infected with different subtypes of human immunodeficiency virus type 1.
Journal of virology 2000;74(10):4888-90.
2000: Leo Heyndrickx; Wouter Janssens; Leopold Zekeng; ROSEMARY MUSONDA; Séverin Anagonou; Gert Van der Auwera; Sandra Coppens; Katleen Vereecken; K De Witte; R Van Rampelbergh; Maina Kahindo; Linda Morison; Francine E McCutchan; Jean K Carr; Jan Albert; M Essex; J Goudsmit; B Asjö; Mika Salminen; Anne Buvé; Guido van der Groen
Simplified strategy for detection of recombinant human immunodeficiency virus type 1 group M isolates by gag/env heteroduplex mobility assay. Study Group on Heterogeneity of HIV Epidemics in African Cities.
Journal of virology 2000;74(1):363-70.
1999: Marianne Jansson; E Backström; Asa Björndal; Viveca Holmberg; Paolo Rossi; Eva Maria Fenyö; M Popovic; Jan Albert; Hans Wigzell
Coreceptor usage and RANTES sensitivity of non-syncytium-inducing HIV-1 isolates obtained from patients with AIDS.
Journal of human virology 1999;2(6):325-38.
1999: C Tscherning-Casper; Nikos Papadogiannakis; M Anvret; L Stolpe; Susanne Lindgren; Ann-Britt Bohlin; Jan Albert; Eva Maria Fenyö
The trophoblastic epithelial barrier is not infected in full-term placentae of human immunodeficiency virus-seropositive mothers undergoing antiretroviral therapy.
Journal of virology 1999;73(11):9673-8.
1999: Jean K Carr; Tiina Laukkanen; Mika Salminen; Jan Albert; A Alaeus; B Kim; eric sanders-buell; Deborah L Birx; Francine E McCutchan
Characterization of subtype A HIV-1 from Africa by full genome sequencing.
AIDS (London, England) 1999;13(14):1819-26.
1999: Sören Andersson; Hans Norrgren; Francisco Dias; Gunnel Biberfeld; Jan Albert
Molecular characterization of human immunodeficiency virus (HIV)-1 and -2 in individuals from guinea-bissau with single or dual infections: predominance of a distinct HIV-1 subtype A/G recombinant in West Africa.
Virology 1999;262(2):312-20.
1999: Göran Bratt; Lars E Eriksson; Eric Sandström; G Gilljam; Jorma Hinkula; Jan Albert; Robert R Redfield; Britta Wahren
Long-term immunotherapy in HIV infection, combined with short-term antiretroviral treatment.
International journal of STD & AIDS 1999;10(8):514-21.
1999: Annette Alaeus; Knut Lidman; A Björkman; J Giesecke; Jan Albert
Similar rate of disease progression among individuals infected with HIV-1 genetic subtypes A-D.
AIDS (London, England) 1999;13(8):901-7.
1999: Asa Björndal; Anders Sönnerborg; C Tscherning; Jan Albert; Eva Maria Fenyö
Phenotypic characteristics of human immunodeficiency virus type 1 subtype C isolates of Ethiopian AIDS patients.
AIDS research and human retroviruses 1999;15(7):647-53.
1999: Andreas Mörner; Asa Björndal; Jan Albert; V N Kewalramani; Dan R Littman; R Inoue; Rigmor Thorstensson; Eva Maria Fenyö; Ewa Björling
Primary human immunodeficiency virus type 2 (HIV-2) isolates, like HIV-1 isolates, frequently use CCR5 but show promiscuity in coreceptor usage.
Journal of virology 1999;73(3):2343-9.
1999: Tiina Laukkanen; Jan Albert; Kirsi Liitsola; S D Green; Jean K Carr; Thomas Leitner; Francine E McCutchan; Mika Salminen
Virtually full-length sequences of HIV type 1 subtype J reference strains.
AIDS research and human retroviruses 1999;15(3):293-7.
1998: Göran Bratt; A Karlsson; Ann-Charlotte Boström; Jan Albert; Britta Wahren; Eric Sandström
Treatment history and baseline viral load, but not viral tropism or CCR-5 genotype, influence prolonged antiviral efficacy of highly active antiretroviral treatment.
AIDS (London, England) 1998;12(16):2193-202.
1998: Jean K Carr; Mika Salminen; Jan Albert; eric sanders-buell; D Gotte; Deborah L Birx; Francine E McCutchan
Full genome sequences of human immunodeficiency virus type 1 subtypes G and A/G intersubtype recombinants.
Virology 1998;247(1):22-31.
1998: T Vener; M Nygren; A Andersson; M Uhlén; Jan Albert; Joakim Lundeberg
Use of multiple competitors for quantification of human immunodeficiency virus type 1 RNA in plasma.
Journal of clinical microbiology 1998;36(7):1864-70.
1998: Göran Bratt; Ann-Charlotte Boström; Jan Albert; Eric Sandström; Britta Wahren
MT-2 tropism and CCR-5 genotype strongly influence disease progression in HIV-1-infected individuals.
AIDS (London, England) 1998;12(7):729-36.
1998: C Tscherning; A Alaeus; R Fredriksson; Asa Björndal; H Deng; Dan R Littman; Eva Maria Fenyö; Jan Albert
Differences in chemokine coreceptor usage between genetic subtypes of HIV-1.
Virology 1998;241(2):181-8.
1998: S Palmer; Annette Alaeus; Jan Albert; S Cox
Drug susceptibility of subtypes A,B,C,D, and E human immunodeficiency virus type 1 primary isolates.
AIDS research and human retroviruses 1998;14(2):157-62.
1997: Asa Björndal; H Deng; Marianne Jansson; J R Fiore; C Colognesi; A Karlsson; Jan Albert; Gabriella Scarlatti; Dan R Littman; Eva Maria Fenyö
Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype.
Journal of virology 1997;71(10):7478-87.
1997: Hans Norrgren; S Marquina; T Leitner; Peter Aaby; Mads Melbye; Anja Poulsen; Olav Larsen; Francisco Dias; D Escanilla; Sören Andersson; Jan Albert; Anders Nauclér
HIV-2 genetic variation and DNA load in asymptomatic carriers and AIDS cases in Guinea-Bissau.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1997;16(1):31-8.
1997: Göran Bratt; Torsten Berglund; B L Glantzberg; Jan Albert; Eric Sandström
Two cases of oral-to-genital HIV-1 transmission.
International journal of STD & AIDS 1997;8(8):522-5.
1997: Annette Alaeus; Knut Lidman; Anders Sönnerborg; Jan Albert
Subtype-specific problems with quantification of plasma HIV-1 RNA.
AIDS (London, England) 1997;11(7):859-65.
1997: Annette Alaeus; Thomas Leitner; Knut Lidman; Jan Albert
Most HIV-1 genetic subtypes have entered Sweden.
AIDS (London, England) 1997;11(2):199-202.
1996: Marianne Jansson; M Popovic; A Karlsson; Fiorenza Cocchi; P Rossi; Jan Albert; Hans Wigzell
Sensitivity to inhibition by beta-chemokines correlates with biological phenotypes of primary HIV-1 isolates.
Proceedings of the National Academy of Sciences of the United States of America 1996;93(26):15382-7.
1996: S Marquina; T Leitner; RD Rabinovich; J Benetucci; O Libonatti; Jan Albert
Coexistence of subtypes B, F, and as B/F env recombinant of HIV type 1 in Buenos Aires Argentina.
AIDS research and human retroviruses 1996;12(17):1651-4.
1996: T Leitner; G Korovina; S Marquina; T Smolskaya; Jan Albert
Molecular epidemiology and MT-2 cell tropism of Russian HIV type 1 variant.
AIDS research and human retroviruses 1996;12(17):1595-603.
1996: T Leitner; D Escanilla; C Franzén; M Uhlén; Jan Albert
Accurate reconstruction of a known HIV-1 transmission history by phylogenetic tree analysis.
Proceedings of the National Academy of Sciences of the United States of America 1996;93(20):10864-9.
1996: T Vener; M Axelsson; Jan Albert; Mathias Uhlén; Joakim Lundeberg
Quantification of HIV-1 using multiple competitors in a single-tube assay.
BioTechniques 1996;21(2):248-52, 253-5.
1996: Jan Albert; Per Stålhandske; S Marquina; J Karis; R A Fouchier; E Norrby; Francesca Chiodi
Biological phenotype of HIV type 2 isolates correlates with V3 genotype.
AIDS research and human retroviruses 1996;12(9):821-8.
1996: Gabriella Scarlatti; Thomas Leitner; V Hodara; Marianne Jansson; A Karlsson; J Wahlberg; P Rossi; M Uhlén; Eva Maria Fenyö; Jan Albert
Interplay of HIV-1 phenotype and neutralizing antibody response in pathogenesis of AIDS.
Immunology letters 1996;51(1-2):23-8.
1995: P Putkonen; L Walther; Y J Zhang; S L Li; Charlotta Nilsson; Jan Albert; P Biberfeld; Rigmor Thorstensson; Gunnel Biberfeld
Long-term protection against SIV-induced disease in macaques vaccinated with a live attenuated HIV-2 vaccine.
Nature medicine 1995;1(9):914-8.
1995: T Leitner; Annette Alaeus; S Marquina; E Lilja; Knut Lidman; Jan Albert
Yet another subtype of HIV type 1?
AIDS research and human retroviruses 1995;11(8):995-7.
1995: T Leitner; D Escanilla; S Marquina; J Wahlberg; C Broström; H B Hansson; M Uhlén; Jan Albert
Biological and molecular characterization of subtype D, G, and A/D recombinant HIV-1 transmissions in Sweden.
Virology 1995;209(1):136-46.
1994: A Karlsson; K Parsmyr; K Aperia; Eric Sandström; Eva Maria Fenyö; Jan Albert
MT-2 cell tropism of human immunodeficiency virus type 1 isolates as a marker for response to treatment and development of drug resistance.
The Journal of infectious diseases 1994;170(6):1367-75.
1994: Josè Ramòn Fiore; Asa Björndal; K A Peipke; M Di Stefano; G Angarano; G Pastore; H Gaines; Eva Maria Fenyö; Jan Albert
The biological phenotype of HIV-1 is usually retained during and after sexual transmission.
Virology 1994;204(1):297-303.
1994: A Valentin; Jan Albert; Eva Maria Fenyö; B Asjö
Dual tropism for macrophages and lymphocytes is a common feature of primary human immunodeficiency virus type 1 and 2 isolates.
Journal of virology 1994;68(10):6684-9.
1994: Jorma Hinkula; Göran Bratt; G Gilljam; S Nordlund; P A Broliden; V Holmberg; E Olausson-Hansson; Jan Albert; Eric Sandström; Britta Wahren
Immunological and virological interactions in patients receiving passive immunotherapy with HIV-1 neutralizing monoclonal antibodies.
Journal of acquired immune deficiency syndromes 1994;7(9):940-51.
1994: Jan Albert; J Wahlberg; T Leitner; D Escanilla; M Uhlén
Analysis of a rape case by direct sequencing of the human immunodeficiency virus type 1 pol and gag genes.
Journal of virology 1994;68(9):5918-24.
1994: Y J Zhang; P Putkonen; Jan Albert; P Ohman; Gunnel Biberfeld; Eva Maria Fenyö
Stable biological and antigenic characteristics of HIV-2SBL6669 in nonpathogenic infection of macaques.
Virology 1994;200(2):583-9.
1994: Marianne Jansson; Britta Wahren; Jan Albert; Gabriella Scarlatti; L Franzén; P K Kataaha; E Katabira; F Mubiro; Hans Wigzell; P Rossi
Peptide serology for analysis of the inter- and intra-individual variation in the HIV-1 V3 domain.
AIDS (London, England) 1994;8(4):413-21.
1994: J Wahlberg; J Fiore; G Angarano; Mathias Uhlén; Jan Albert
Apparent selection against transmission of zidovudine-resistant human immunodeficiency virus type 1 variants.
The Journal of infectious diseases 1994;169(3):611-4.
1994: A Karlsson; K Parsmyr; Eric Sandström; Eva Maria Fenyö; Jan Albert
MT-2 cell tropism as prognostic marker for disease progression in human immunodeficiency virus type 1 infection.
Journal of clinical microbiology 1994;32(2):364-70.
1993: Gabriella Scarlatti; V Hodara; P Rossi; L Muggiasca; Anna Maria Bucceri; Jan Albert; Eva Maria Fenyö
Transmission of human immunodeficiency virus type 1 (HIV-1) from mother to child correlates with viral phenotype.
Virology 1993;197(2):624-9.
1993: Y J Zhang; P Ohman; P Putkonen; Jan Albert; L Walther; Per Stålhandske; Gunnel Biberfeld; Eva Maria Fenyö
Autologous neutralizing antibodies to SIVsm in cynomolgus monkeys correlate to prognosis.
Virology 1993;197(2):609-15.
1993: Gabriella Scarlatti; Thomas Leitner; V Hodara; Eva Halapi; P Rossi; Jan Albert; Eva Maria Fenyö
Neutralizing antibodies and viral characteristics in mother-to-child transmission of HIV-1.
AIDS (London, England) 1993;7 Suppl 2():S45-8.
1993: Gabriella Scarlatti; Thomas Leitner; Eva Halapi; J Wahlberg; Marianne Jansson; Hans Wigzell; Eva Maria Fenyö; Jan Albert; M Uhlén; P Rossi
Analysis of the HIV-1 envelope V3-loop sequences from ten mother-child pairs.
Annals of the New York Academy of Sciences 1993;693():277-80.
1993: Gabriella Scarlatti; Jan Albert; P Rossi; V Hodara; P Biraghi; L Muggiasca; Eva Maria Fenyö
Mother-to-child transmission of human immunodeficiency virus type 1: correlation with neutralizing antibodies against primary isolates.
The Journal of infectious diseases 1993;168(1):207-10.
1993: Thomas Leitner; Eva Halapi; Gabriella Scarlatti; P Rossi; Jan Albert; E M Fenyö; M Uhlén
Analysis of heterogeneous viral populations by direct DNA sequencing.
BioTechniques 1993;15(1):120-7.
1993: Jan Albert; Ewa Björling; A von Gegerfelt; Gabriella Scarlatti; Y J Zhang; Eva Maria Fenyö; Rigmor Thorstensson
Antigen detection is a reliable method for evaluating HIV/SIV neutralization assays.
AIDS research and human retroviruses 1993;9(6):501-4.
1993: Gabriella Scarlatti; Thomas Leitner; Eva Halapi; J Wahlberg; Paola Marchisio; M A Clerici-Schoeller; Hans Wigzell; Eva Maria Fenyö; Jan Albert; M Uhlén
Comparison of variable region 3 sequences of human immunodeficiency virus type 1 from infected children with the RNA and DNA sequences of the virus populations of their mothers.
Proceedings of the National Academy of Sciences of the United States of America 1993;90(5):1721-5.
1993: Ewa Björling; Gabriella Scarlatti; A von Gegerfelt; Jan Albert; Gunnel Biberfeld; Francesca Chiodi; E Norrby; Eva Maria Fenyö
Autologous neutralizing antibodies prevail in HIV-2 but not in HIV-1 infection.
Virology 1993;193(1):528-30.
1993: E Lucht; Jan Albert; A Linde; W Xu; Maria Brytting; J Lundeberg; M Uhlén; Göran Bratt; Eric Sandström; A Heimdahl
Human immunodeficiency virus type 1 and cytomegalovirus in saliva.
Journal of medical virology 1993;39(2):156-62.
1993: S W Cox; Jan Albert; E Ljungdahl-Ståhle; Britta Wahren
Effect of resistance on combination chemotherapy for human immunodeficiency virus infection.
Advances in enzyme regulation 1993;33():27-36.
1992: Jan Albert; L Franzén; Marianne Jansson; Gabriella Scarlatti; P K Kataaha; E Katabira; F Mubiro; M Rydåker; P Rossi; U Pettersson
Ugandan HIV-1 V3 loop sequences closely related to the U.S./European consensus.
Virology 1992;190(2):674-81.
1992: Jan Albert; J Wahlberg; J Lundeberg; S Cox; Eric Sandström; Britta Wahren; M Uhlén
Persistence of azidothymidine-resistant human immunodeficiency virus type 1 RNA genotypes in posttreatment sera.
Journal of virology 1992;66(9):5627-30.
1992: Francesca Chiodi; B Keys; Jan Albert; L Hagberg; J Lundeberg; M Uhlén; Eva Maria Fenyö; G Norkrans
Human immunodeficiency virus type 1 is present in the cerebrospinal fluid of a majority of infected individuals.
Journal of clinical microbiology 1992;30(7):1768-71.
1992: S W Cox; Jan Albert; J Wahlberg; M Uhlén; Britta Wahren
Loss of synergistic response to combinations containing AZT in AZT-resistant HIV-1.
AIDS research and human retroviruses 1992;8(7):1229-34.
1992: A Valentin; Jan Albert; stefan svenson; B Asjö
Blood-derived macrophages produce IL-1, but not TNF-alpha, after infection with HIV-1 isolates from patients at different stages of disease.
Cytokine 1992;4(3):185-91.
1992: P Putkonen; Rigmor Thorstensson; Martin Cranage; Charlotta Nilsson; L Ghavamzadeh; Jan Albert; P Greenaway; Gunnel Biberfeld
A formalin inactivated whole SIVmac vaccine in Ribi adjuvant protects against homologous and heterologous SIV challenge.
Journal of medical primatology 1992;21(2-3):108-12.
1992: O Grankvist; U Bredberg-Rådèn; A Gustafsson; Jan Albert; P Albino; P A Andreasson; Anders Nauclér; Gunnel Biberfeld; Göran Wadell
Improved detection of HIV-2 DNA in clinical samples using a nested primer-based polymerase chain reaction.
Journal of acquired immune deficiency syndromes 1992;5(3):286-93.
1991: J Wahlberg; Jan Albert; J Lundeberg; A Von Gegerfelt; Kristina Broliden; G Utter; Eva Maria Fenyö; M Uhlén
Analysis of the V3 loop in neutralization-resistant human immunodeficiency virus type 1 variants by direct solid-phase DNA sequencing.
AIDS research and human retroviruses 1991;7(12):983-90.
1991: A Von Gegerfelt; Jan Albert; L Morfeldt-Månson; Kristina Broliden; Eva Maria Fenyö
Isolate-specific neutralizing antibodies in patients with progressive HIV-1-related disease.
Virology 1991;185(1):162-8.
1991: B Keys; Jan Albert; J Kövamees; Francesca Chiodi
Brain-derived cells can be infected with HIV isolates derived from both blood and brain.
Virology 1991;183(2):834-9.
1991: P Putkonen; Rigmor Thorstensson; L Ghavamzadeh; Jan Albert; K Hild; Gunnel Biberfeld; E Norrby
Prevention of HIV-2 and SIVsm infection by passive immunization in cynomolgus monkeys.
Nature 1991;352(6334):436-8.
1991: P Putkonen; Rigmor Thorstensson; L Walther; Jan Albert; Lennart Akerblom; O Granquist; Göran Wadell; E Norrby; Gunnel Biberfeld
Vaccine protection against HIV-2 infection in cynomolgus monkeys.
AIDS research and human retroviruses 1991;7(3):271-7.
1991: Rigmor Thorstensson; L Walther; P Putkonen; Jan Albert; Gunnel Biberfeld
A capture enzyme immunoassay for detection of HIV-2/SIV antigen.
Journal of acquired immune deficiency syndromes 1991;4(4):374-9.
1991: E Norrby; P Putkonen; Jan Albert; Eva Maria Fenyö
Immunodominant antigenic sites in primate immunodeficiency viruses and in vivo protection.
Biotechnology therapeutics 1991;2(1-2):21-9.
1990: B Asjö; U K Sharma; L Morfeldt-Månson; A Magnusson; T Barkhem; Jan Albert; E Olausson; A Von Gegerfelt; B Lind; P Biberfeld
Naturally occurring HIV-1 isolates with differences in replicative capacity are distinguished by in situ hybridization of infected cells.
AIDS research and human retroviruses 1990;6(10):1177-82.
1990: S Cox; U Rudén; Karoly Nagy; Jan Albert; V Holmberg; Eric Sandström; Britta Wahren
Serum levels and catabolism of 3'-azido-3'-deoxythymidine in vivo measured using a specific radioimmunoassay.
Journal of virological methods 1990;30(1):89-98.
1990: A Valentin; Jan Albert; Eva Maria Fenyö; B Asjö
HIV-1 infection of normal human macrophage cultures: implication for silent infection.
Virology 1990;177(2):790-4.
1990: P Putkonen; Rigmor Thorstensson; Jan Albert; K Hild; E Norrby; Peter Biberfeld; Gunnel Biberfeld
Infection of cynomolgus monkeys with HIV-2 protects against pathogenic consequences of a subsequent simian immunodeficiency virus infection.
AIDS (London, England) 1990;4(8):783-9.
1990: Jan Albert; Eva Maria Fenyö
Simple, sensitive, and specific detection of human immunodeficiency virus type 1 in clinical specimens by polymerase chain reaction with nested primers.
Journal of clinical microbiology 1990;28(7):1560-4.
1990: Jan Albert; Anders Nauclér; B Böttiger; P A Broliden; P Albino; S A Ouattara; C Björkegren; A Valentin; Gunnel Biberfeld; Eva Maria Fenyö
Replicative capacity of HIV-2, like HIV-1, correlates with severity of immunodeficiency.
AIDS (London, England) 1990;4(4):291-5.
1990: Jan Albert; B Abrahamsson; K Nagy; E Aurelius; Hans Gaines; G Nyström; Eva Maria Fenyö
Rapid development of isolate-specific neutralizing antibodies after primary HIV-1 infection and consequent emergence of virus variants which resist neutralization by autologous sera.
AIDS (London, England) 1990;4(2):107-12.
1989: K Ljunggren; Francesca Chiodi; P A Broliden; Jan Albert; G Norkrans; L Hagberg; Mikael Jondal; Eva Maria Fenyö
HIV-1-specific antibodies in cerebrospinal fluid mediate cellular cytotoxicity and neutralization.
AIDS research and human retroviruses 1989;5(6):629-38.
1989: Francesca Chiodi; A Valentin; B Keys; S Schwartz; B Asjö; Suzanne Gartner; M Popovic; Jan Albert; V A Sundqvist; Eva Maria Fenyö
Biological characterization of paired human immunodeficiency virus type 1 isolates from blood and cerebrospinal fluid.
Virology 1989;173(1):178-87.
1989: V A Sundqvist; Jan Albert; E Ohlsson; Jorma Hinkula; Eva Maria Fenyö; Britta Wahren
Human immunodeficiency virus type 1 p24 production and antigenic variation in tissue culture of isolates with various growth characteristics.
Journal of medical virology 1989;29(3):170-5.
1989: Francesca Chiodi; T Mathiesen; Jan Albert; E Parks; E Norrby; Britta Wahren
IgG subclass responses to a transmembrane protein (gp41) peptide in HIV infection.
Journal of immunology (Baltimore, Md. : 1950) 1989;142(11):3809-14.
1989: T Mathiesen; Francesca Chiodi; P A Broliden; Jan Albert; R A Houghten; G Utter; Britta Wahren; E Norrby
Analysis of a subclass-restricted HIV-1 gp41 epitope by omission peptides.
Immunology 1989;67(1):1-7.
1989: P Putkonen; K Warstedt; Rigmor Thorstensson; R Benthin; Jan Albert; B Lundgren; B Oberg; E Norrby; Gunnel Biberfeld
Experimental infection of cynomolgus monkeys (Macaca fascicularis) with simian immunodeficiency virus (SIVsm).
Journal of acquired immune deficiency syndromes 1989;2(4):359-65.
1989: P Putkonen; B Böttiger; K Warstedt; Rigmor Thorstensson; Jan Albert; Gunnel Biberfeld
Experimental infection of cynomolgus monkeys (Macaca fascicularis) with HIV-2.
Journal of acquired immune deficiency syndromes 1989;2(4):366-73.
1989: Eva Maria Fenyö; Jan Albert; B Asjö
Replicative capacity, cytopathic effect and cell tropism of HIV.
AIDS (London, England) 1989;3 Suppl 1():S5-12.
1988: T Mathiesen; V A Sundqvist; Jan Albert; E Ohlsson; Britta Wahren
Acid hydrolysis of serum samples to increase detection of HIV antigen.
Journal of virological methods 1988;22(2-3):143-8.
1988: Eva Maria Fenyö; L Morfeldt-Månson; Francesca Chiodi; B Lind; A von Gegerfelt; Jan Albert; E Olausson; B Asjö
Distinct replicative and cytopathic characteristics of human immunodeficiency virus isolates.
Journal of virology 1988;62(11):4414-9.
1988: Francesca Chiodi; Jan Albert; E Olausson; G Norkrans; L Hagberg; Anders Sönnerborg; B Asjö; Eva Maria Fenyö
Isolation frequency of human immunodeficiency virus from cerebrospinal fluid and blood of patients with varying severity of HIV infection.
AIDS research and human retroviruses 1988;4(5):351-8.
1988: Francesca Chiodi; Anders Sönnerborg; Jan Albert; Hans Gaines; G Norkrans; L Hagberg; B Asjö; O Strannegård; Eva Maria Fenyö
Human immunodeficiency virus infection of the brain. I. Virus isolation and detection of HIV specific antibodies in the cerebrospinal fluid of patients with varying clinical conditions.
Journal of the neurological sciences 1988;85(3):245-57.
1988: Jan Albert; P O Pehrson; S Schulman; C Håkansson; G B Lövhagen; O Berglund; S Beckman; Eva Maria Fenyö
HIV isolation and antigen detection in infected individuals and their seronegative sexual partners.
AIDS (London, England) 1988;2(2):107-11.
1988: B Asjö; Jan Albert; F Chiodi; E M Fenyö
Improved tissue culture technique for production of poorly replicating human immunodeficiency virus strains.
Journal of virological methods 1988;19(3-4):191-6.
1988: P Putkonen; Jan Albert; A Karlsson; P O Persson; K Karlén; K Hjalmarsson; R Norberg
Group specific component and susceptibility to HIV infection and progression to AIDS.
Scandinavian journal of infectious diseases 1988;20(1):11-4.
1987: Francesca Chiodi; A von Gegerfeldt; Jan Albert; E M Fenyö; Hans Gaines; M von Sydow; Gunnel Biberfeld; E Parks; E Norrby
Site-directed ELISA with synthetic peptides representing the HIV transmembrane glycoprotein.
Journal of medical virology 1987;23(1):1-9.
1987: Jan Albert; Hans Gaines; Anders Sönnerborg; G Nyström; P O Pehrson; Francesca Chiodi; M von Sydow; L Moberg; Knut Lidman; B Christensson
Isolation of human immunodeficiency virus (HIV) from plasma during primary HIV infection.
Journal of medical virology 1987;23(1):67-73.
1986: B Asjö; L Morfeldt-Månson; Jan Albert; Gunnel Biberfeld; A Karlsson; K Lidman; Eva Maria Fenyö
Replicative capacity of human immunodeficiency virus from patients with varying severity of HIV infection.
Lancet 1986;2(8508):660-2.